Management of Morgellons Disease With Low-Dose Trifluoperazine.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 29322188.
- Also identified by DOI 10.1001/jamadermatol.2017.5175 and PMC identifier 5839272.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This medical record review examines the novel use of low-dose trifluoperazine, a high-potency typical antipsychotic, in a cohort of patients with Morgellons disease.
Medical subject headings
- Antipsychotic Agents
- Morgellons Disease
- Trifluoperazine